A drug that extends life span prevents Alzheimer’s deficits

April 12, 2010

If research results continue to be repeated and are turned into clinical trials, a drug already approved for some uses could be marshaled — sooner than we expect — to prevent Alzheimer’s disease in humans and improve health to the end of life.





San Antonio study examines investigational drug for Alzheimer’s

June 6, 2006

San Antonio residents diagnosed with Alzheimer’s disease may be eligible to participate in a clinical study offered by the Health Science Center. The study will assess whether an investigational drug, Flurizan, can slow Alzheimer’s progression.